Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2012109387) COMPOSITION AND LIPID FORMULATION OF A HYALURONAN-DEGRADING ENZYME AND THE USE THEREOF FOR TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2012/109387 International Application No.: PCT/US2012/024376
Publication Date: 16.08.2012 International Filing Date: 08.02.2012
Chapter 2 Demand Filed: 06.12.2012
IPC:
A61K 9/127 (2006.01) ,A61K 38/00 (2006.01) ,A61K 38/47 (2006.01) ,A61K 47/24 (2006.01) ,A61K 9/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
10
Dispersions; Emulsions
127
Liposomes
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
43
Enzymes; Proenzymes; Derivatives thereof
46
Hydrolases (3)
47
acting on glycosyl compounds (3.2), e.g. cellulases, lactases
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
06
Organic compounds
24
containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen or sulfur
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
Applicants:
HALOZYME, INC. [US/US]; 11388 Sorrento Valley Road San Diego, CA 92121, US (AllExceptUS)
LI, Xiaoming [US/US]; US (UsOnly)
RAMPRASAD, Mysore [US/US]; US (UsOnly)
THOMPSON, Curtis [US/US]; US (UsOnly)
SHEPARD, Harold, Michael [US/US]; US (UsOnly)
BOOKBINDER, Louis, Howard [US/US]; US (UsOnly)
FROST, Gregory, Ian [US/US]; US (UsOnly)
Inventors:
LI, Xiaoming; US
RAMPRASAD, Mysore; US
THOMPSON, Curtis; US
SHEPARD, Harold, Michael; US
BOOKBINDER, Louis, Howard; US
FROST, Gregory, Ian; US
Agent:
SEIDMAN, Stephanie, L.; McKenna Long & Aldridge LLP 4435 Eastgate Mall, Suite 400 San Diego, CA 92121, US
BALDOCK, Sharon, Claire; Boult Wade Tennant Verulam Gardens 70 Gray´s Inn Road London WC1X 8BT, GB
Priority Data:
61/462,87508.02.2011US
Title (EN) COMPOSITION AND LIPID FORMULATION OF A HYALURONAN-DEGRADING ENZYME AND THE USE THEREOF FOR TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
(FR) COMPOSITION ET FORMULATION LIPIDIQUE D'UNE ENZYME DÉGRADANT LE HYALURONANE ET SON UTILISATION POUR LE TRAITEMENT DE L'HYPERPLASIE BÉNIGNE DE LA PROSTATE
Abstract:
(EN) Provided are compositions and formulations or co-formulations containing a hyaluronan degrading enzyme. The compositions, formulations or co-formulations can also contain another therapeutic agent, such as one that is suitable for treatment of Benign Prostatic Hyperplasia, for example, a 5-alpha reductase inhibitors. The compositions and formulations can be used for the treatment of Benign Prostatic Hyperplasia. The compositions and formulations can be provided in combinations with one or more other agents for the treatment of Benign Prostatic Hyperplasia.
(FR) L'invention concerne des compositions et des formulations ou des co-formulations contenant une enzyme dégradant le hyaluronane. Les compositions, formulations ou co-formulations peuvent également contenir un autre agent thérapeutique, comme un agent approprié au traitement de l'hyperplasie bénigne de la prostate, par exemple, des inhibiteurs de 5-alpha réductase. Les compositions et formulations peuvent être utilisées pour le traitement de l'hyperplasie bénigne de la prostate. Les compositions et formulations peuvent être fournies en combinaisons avec un ou plusieurs agents pour le traitement de l'hyperplasie bénigne de la prostate.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
JP2014510045EP2672958EP2907504JP2017141228JP2018172429